Tailored Expertise Sourcing & Market Intelligence in Global Consulting

Professionals and companies frequently need immediate and precise insights in today's quick-paced, information-driven environment to make wise decisions. Expert network services have become a useful tool for gaining access to information and expertise particular to a given sector. Expert network services may be useful for anybody seeking financial advice, whether they are a hedge fund manager or a pharmaceutical firm. This article will explore the key details you should know about expert network services.

Reeracoen Singapore Pte Ltd, a leading provider of human resource services in Singapore, is proud to announce the launch of their new Expert Network Service (ENS), Brainsight. An extension to Reeracoen's current suite of services, Brainsight provides companies with comprehensive knowledge and business intelligence. As a leading recruitment firm that has established connections with companies in different industries, Reeracoen identified that they were well placed to help companies make the right business connections. By gaining access to a network of relevant experts, companies can better manage their resources by gaining a targeted insight into their intended market, assess the viability of new or prospective businesses and get to know prospective business partners.

Our AI-powered tech searches and indexes billions of online data points in real-time to find the most precise expert you need. Learn more about how we can help here.

Electricals giant Currys has built an almost £700m business through repairs and returns - and it has plans to make it even bigger. Retail Gazette visits its tech repairs hub - Europe's biggest - in Newark to find out more.

New data released by Defra reveals that England’s material footprint fell to 783 million tonnes in 2020. Material footprintThe figure represents an 11.1 per cent fall from 2019, where England's material footprint sat at 880 million tonnes. ‘Material footprint’ refers to the total allocation of primary raw material extraction to meet the final demand for goods and services within a country.

Quatre grands objectifs ont été mis en avant pour la constitution de ce futur référentiel avec la conception de services numériques plus durables afin d’allonger la durée de vie des terminaux, la promotion d’une démarche de sobriété environnementale, la diminution des ressources informatiques mobilisées (optimisation du trafic, sollicitation des infrastructures numériques) ainsi qu’une plus grande transparence de l’empreinte environnementale des services numériques comme le streaming.

Our study provides a nanovesicle-based delivery platform to promote the efficacy of chemotherapeutic drugs with fewer side effects. This novel strategy may ameliorate the present obstacles to the clinical treatment of lung cancer.

Over the past 20 years, nanotechnologies have provided alternative and complementary solutions to those of an exclusively pharmaceutical chemical nature since scientists and clinicians invested in the optimization of materials and methods capable of regulating effective drug delivery at the nanometer scale. Among the many drug delivery carriers, lipid nano vesicular ones successfully support clinical candidates approaching such problems as insolubility, biodegradation, and difficulty in overcoming the skin and biological barriers such as the blood–brain one.

Transfersomes are elastic in nature, which can deform and squeeze themselves as an intact vesicle through narrow pores that are significantly smaller than its size.

The conventional therapeutic approaches to treat autoimmune diseases through suppressing the immune system, such as steroidal and non-steroidal anti-inflammatory drugs, are not adequately practical. Moreover, these regimens are associated with considerable complications. Designing tolerogenic therapeutic strategies based on stem cells, immune cells, and their extracellular vesicles (EVs) seems to open a promising path to managing autoimmune diseases’ vast burden.

Plant-derived extracellular vesicles (EVs) may represent a platform for the delivery of RNA-based vaccines, exploiting their natural membrane envelope to protect and deliver nucleic acids. Here, EVs extracted from orange (Citrus sinensis) juice (oEVs) were investigated as carriers for oral and intranasal SARS-CoV-2 mRNA vaccine. oEVs were efficiently loaded with different mRNA molecules (coding N, subunit 1 and full S proteins) and the mRNA was protected from degrading stress (including RNase and simulated gastric fluid), delivered to target cells and translated into protein. APC cells stimulated with oEVs loaded with mRNAs induced T lymphocyte activation in vitro.

The company’s novel Mercy Halo™ platform unlocks high clinical sensitivity and specificity through the simultaneous detection of multiple cancer-related biomarkers co-localized on the surface of individual tumor-derived extracellular vesicles. The abundance of extracellular vesicles in circulation enables the Mercy Halo test to be run on a very small volume of serum or plasma with a simple PCR-based read-out.

Liquid biopsy has completely transformed clinical oncology, creating a new dimension for cancer care with personalized treatment. This minimally invasive technique is highly beneficial in providing better clinical outcomes by identifying actionable cancer biomarkers, early diagnosis, and easing tumor sampling, especially when solid tissue biopsies are insufficient or unable to obtain.

Smaller consultancy and due-diligence firms in China reckon they stand to gain once business returns to normal after the shock administered by Beijing's crackdown on firms supplying information deemed too sensitive to be shared with foreigners. The crackdown, which ensnared Shanghai-based market leader Capvision earlier this month, and a sweeping update to anti-espionage legislation that comes into effect from July 1, has made some consultants in the country scramble to reduce risk.

China's clampdown on its consultancy and due diligence sector has driven companies to review their operations after some tested the limits of the laws and Beijing's patience to meet surging demand as China emerged from its COVID-lockdowns. These consultancies thrived by providing investors - from global hedge funds to private equity firms - access to industry experts and investigators who could obtain valuable corporate information.

The Commission’s proposal, part of The Strategic Action Plan on Batteries, published in May 2018, contains a variety of requirements and restrictions in order to minimize batteries’ environmental impact.

Le 1er avril, la Zoe tirera sa révérence après douze ans de présence au catalogue et 420 000 ventes au compteur. Renault aura alors tourné une page importante de son histoire sur laquelle figurent des noms mythiques : Dauphine, 4L, R5, Clio ou encore Twingo. L’arrêt de la Zoe marquera une étape majeure du renouveau de Flins, puisque plus aucune voiture neuve ne sortira de ses chaînes. Une première depuis 1952, date d’inauguration de l’usine située en lisière du Vexin. Devenue Refactory, Flins se targue d’être le "premier site européen dédié à l’économie

Learn what a circular economy means for your company, its products, and what opportunities lie for those who embrace customer demands for sustainability and environmental transparency.

Product circularity is one of the circular economy principles that will help businesses transition to a more environmentally prosperous future.

The Center for Breakthrough Medicines (CBM) offers a purpose-built manufacturing facility, with over twenty suites focused on scalable production of viral vectors, including Adeno-associated virus (AAV), Lentivirus (LV), HSV, Adenovirus, and other vectors.
Our end-to-end vector manufacturing capabilities consistently deliver high yields and higher throughput without compromising quality to accelerate the availability of new therapies to patients who need them.

Lipid-based vaccine delivery systems such as the conventional liposomes, virosomes, bilosomes, vesosomes, pH-fusogenic liposomes, transferosomes, immuno-liposomes, ethosomes, and lipid nanoparticles have gained a remarkable interest in vaccine delivery due to their ability to render antigens in vesicular structures, that in turn prevents its enzymatic degradation in vivo. The particulate form of lipid-based nanocarriers confers immunostimulatory potential, making them ideal antigen carriers. Facilitation in the uptake of antigen-loaded nanocarriers, by the antigen-presenting cells and its subsequent presentation through the major histocompatibility complex molecules, leads to the activation of a cascade of immune responses.

In vivo studies confirmed antibacterial effects of RJEVs and demonstrated an acceleration of wound healing in a splinted mouse model. This study suggests that RJEVs play a crucial role in the known effects of RJ by modulating the inflammatory phase and cellular response in wound healing. Transfer of RJ into the clinics has been impeded by the high complexity of the raw material. Isolating EVs from the raw RJ decreases the complexity while allowing standardization and quality control, bringing a natural nano-therapy one step closer to the clinics.

Vascular smooth muscle cell (VSMC)-derived small extracellular vesicles (sEVs) are key mediators of medin accumulation in the vessel wall. In addition, the authors identify, for the first time, a role for cellular senescence in triggering amyloidosis via changes in sEVs and extracellular matrix (ECM) composition. Thus, this study not only advances our understanding of how AMA is formed but uncovers potential therapeutic targets for mitigating the detrimental effects of amyloidosis on tissue function.

Sepsis is a syndromic response to infection and is frequently a final common pathway to death from many infectious diseases worldwide. The complexity and high heterogeneity of sepsis hinder the possibility to treat all patients with the same protocol, requiring personalized management. The versatility of extracellular vesicles (EVs) and their contribution to sepsis progression bring along promises for one-to-one tailoring sepsis treatment and diagnosis.

EV-derived miRNAs, lncRNAs, mRNAs, and proteins may serve as biomarkers for both BC diagnosis and prognostication. Not only might they improve patient care through a more precise and minimally invasive strategy, but they might aid in overcoming contemporary challenges in the field. Importantly, technical issues still hamper their use in a clinical setting. Nonetheless, research on EVs is advancing at a fast pace, showing their great potential as a source of biomarkers, which further emphasizes the value that EV-derived molecules may have in the clinical management of BC patients.